A method of inducing an immune response using vaccinia virus recombinants
CA 2190290 C · Owner: Eisenlohr, Laurence C. · Inventors: Berd, David; Mastrangelo, Michael J.; Lattime, Edmund C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of inducing expression of immune active cytokines in tumors in situ is provided wherein a vaccinia virus vector capable of inducing expression of a selected cytokine is generated and injected into a tumor so that cells of the tumor express the selected cytokine. A method of enhancing immunity in a host by administration of a vaccinia virus vector is also provided. Methods of treating cancer by administration of these vaccinia virus vectors are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 11, 1995 and granted July 5, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 11, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 11, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.